Albert Yu, Chairman of the Hong Kong Biotechnology Organization, shares his insights on Hong Kong’s potential to become an innovation hub for the region while positioning Hong Kong as the ‘Chinese City outside of China.’ In addition, he discusses the main trends that will drive development of HK’s biotechnology sector in the future.
Looking at the biotech landscape in Hong Kong, we know there are a lot of inherent positives for the industry, for example easy access to all of South East Asia. What do you believe are the other benefits that Hong Kong offers the industry?
"Leveraging factors to the industry’s success such as opportunities, security, and a multilingual environment - can all be found in one place: Hong Kong."
